Global Benign Prostatic Hyperplasia Treatment Market Report 2022-2030: Minimally Invasive Procedures are Gaining Wide Acceptance and Rising Demand for Alpha-Blockers Among Patients Dublin, Feb. 07, 2023 (GLOBE NEWSWIRE) -- The "Benign Prostatic Hyperplasia Treatment Market Size Analysis Report by Type, End User - Industry Analysis Forecast to 2030" report has been added to ...

Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market is Anticipated to Attain a Valuation of US$ 39.5 Bn Steady CAGR of 4.7% by the end of year 2028. Analysis by Future Market Insights, Inc. NEWARK, Del, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The global benign prostatic hyperplasia (BPH) prostate treatment market is expected to reach a valuation of US$ 39.5 Bn in 2028, with demand growing at...

The Worldwide Benign Prostatic Hyperplasia Treatment Industry is Expected to Reach $14.1 Billion by 2026 at a CAGR of 5.3% from 2021 Dublin, March 30, 2021 (GLOBE NEWSWIRE) -- The "Benign Prostatic Hyperplasia Treatment Market by Type (Drug (Alpha Blockers(Tamsulosin, Doxazosin), 5-Alpha Reductase Inhibitors (Finasteride,...